|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
107,850,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Vaxcyte is a clinical-stage vaccine company. Co. is developing conjugate and protein vaccines to treat bacterial infectious diseases. Co.'s primary vaccine candidate, VAX-24, is a 24-valent investigational pneumococcal conjugate vaccine (PCV) for the treatment of invasive pneumococcal disease and pneumonia. Co.'s second PCV candidate, VAX-XP, is designed to expand the breadth of coverage to greater than 30 strains without compromising immunogenicity due to carrier suppression. In addition, Co.'s pipeline includes VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep and VAX-PG, a protein vaccine candidate targeting the keystone pathogen responsible for periodontitis.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
83,566 |
292,093 |
389,947 |
579,547 |
Total Sell Value |
$5,551,567 |
$19,764,414 |
$24,649,785 |
$29,657,922 |
Total People Sold |
4 |
6 |
6 |
8 |
Total Sell Transactions |
12 |
35 |
47 |
81 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Pickering Grant |
Chief Executive Officer |
|
2021-07-20 |
4 |
AS |
$22.85 |
$342,686 |
D/D |
(15,000) |
580,254 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2021-07-20 |
4 |
OE |
$1.79 |
$26,850 |
D/D |
15,000 |
595,254 |
|
- |
|
Fairman Jeff |
VP, Research |
|
2021-06-28 |
4 |
AS |
$24.36 |
$115,770 |
D/D |
(4,750) |
5,144 |
|
- |
|
Fairman Jeff |
VP, Research |
|
2021-06-28 |
4 |
OE |
$1.79 |
$8,503 |
D/D |
4,750 |
9,894 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2021-06-24 |
4 |
AS |
$22.85 |
$320,123 |
D/D |
(13,863) |
580,254 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2021-06-24 |
4 |
OE |
$1.79 |
$24,815 |
D/D |
13,863 |
594,117 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2021-06-22 |
4 |
AS |
$22.00 |
$1,628 |
D/D |
(74) |
580,254 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2021-06-22 |
4 |
OE |
$1.79 |
$132 |
D/D |
74 |
580,328 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2021-06-21 |
4 |
AS |
$22.05 |
$23,439 |
D/D |
(1,063) |
580,254 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2021-06-21 |
4 |
OE |
$1.79 |
$1,903 |
D/D |
1,063 |
581,317 |
|
- |
|
Fairman Jeff |
VP, Research |
|
2021-06-07 |
4 |
AS |
$22.50 |
$213,750 |
D/D |
(9,500) |
5,144 |
|
- |
|
Fairman Jeff |
VP, Research |
|
2021-06-07 |
4 |
OE |
$0.04 |
$4,302 |
D/D |
9,500 |
14,644 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2021-06-04 |
4 |
AS |
$22.14 |
$179,179 |
D/D |
(8,093) |
580,254 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2021-06-04 |
4 |
OE |
$1.79 |
$14,486 |
D/D |
8,093 |
588,347 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2021-06-03 |
4 |
AS |
$22.11 |
$154,881 |
D/D |
(7,005) |
580,254 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2021-06-03 |
4 |
OE |
$1.79 |
$12,539 |
D/D |
7,005 |
587,259 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2021-05-28 |
4 |
AS |
$22.16 |
$58,857 |
D/D |
(2,656) |
580,254 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2021-05-28 |
4 |
OE |
$1.79 |
$4,754 |
D/D |
2,656 |
582,910 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2021-05-27 |
4 |
AS |
$22.10 |
$270,637 |
D/D |
(12,246) |
580,254 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2021-05-27 |
4 |
OE |
$1.79 |
$21,920 |
D/D |
12,246 |
592,500 |
|
- |
|
Fairman Jeff |
VP, Research |
|
2021-04-22 |
4 |
OE |
$1.79 |
$4,999 |
D/D |
2,793 |
4,201 |
|
- |
|
Sauer Paul |
SVP Process Dev, Manufacturing |
|
2021-04-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(38,308) |
39,591 |
|
- |
|
Fairman Jeff |
VP, Research |
|
2021-03-26 |
4 |
AS |
$23.64 |
$113,433 |
D/D |
(4,750) |
1,408 |
|
- |
|
Fairman Jeff |
VP, Research |
|
2021-03-26 |
4 |
OE |
$0.04 |
$190 |
D/D |
4,750 |
6,158 |
|
- |
|
Pickering Grant |
President & CEO |
|
2021-03-19 |
4 |
AS |
$25.77 |
$386,550 |
D/D |
(15,000) |
578,691 |
|
- |
|
349 Records found
|
|
Page 11 of 14 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|